Phase I/Ii Study of Gefitinib (Iressa®) and Vorinostat (IVORI) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-014-2664-9
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
Springer Science and Business Media LLC